SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15709091
Source:
http://linkedlifedata.com/resource/pubmed/id/15709091
Search
Subject
(
64
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0006826
,
umls-concept:C0008838
,
umls-concept:C0020823
,
umls-concept:C0030705
,
umls-concept:C0036525
,
umls-concept:C0037390
,
umls-concept:C0238378
,
umls-concept:C0246415
,
umls-concept:C0439611
,
umls-concept:C0684224
,
umls-concept:C1521750
,
umls-concept:C1522484
pubmed:issue
2
pubmed:dateCreated
2005-2-14
pubmed:abstractText
The aim of this study was to evaluate the efficacy and toxicity of a new combination chemotherapy of docetaxel, ifosfamide and cisplatin (DIP) in the treatment of metastatic urothelial cancer.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0313225
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Ifosfamide
,
http://linkedlifedata.com/resource/pubmed/chemical/Taxoids
,
http://linkedlifedata.com/resource/pubmed/chemical/docetaxel
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0368-2811
pubmed:author
pubmed-author:KitamuraTadaichiT
,
pubmed-author:KumeHarukiH
,
pubmed-author:MatsumotoShinyaS
,
pubmed-author:NishimatsuHiroakiH
,
pubmed-author:OkamotoNaohikoN
,
pubmed-author:SuzukiMakotoM
,
pubmed-author:TakahashiSatoruS
,
pubmed-author:TomitaKyoichiK
pubmed:issnType
Print
pubmed:volume
35
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
79-83
pubmed:dateRevised
2006-4-24
pubmed:meshHeading
pubmed-meshheading:15709091-Aged
,
pubmed-meshheading:15709091-Aged, 80 and over
,
pubmed-meshheading:15709091-Agranulocytosis
,
pubmed-meshheading:15709091-Anemia
,
pubmed-meshheading:15709091-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:15709091-Bone Neoplasms
,
pubmed-meshheading:15709091-Cisplatin
,
pubmed-meshheading:15709091-Drug Administration Schedule
,
pubmed-meshheading:15709091-Female
,
pubmed-meshheading:15709091-Humans
,
pubmed-meshheading:15709091-Ifosfamide
,
pubmed-meshheading:15709091-Lung Neoplasms
,
pubmed-meshheading:15709091-Lymphatic Metastasis
,
pubmed-meshheading:15709091-Male
,
pubmed-meshheading:15709091-Middle Aged
,
pubmed-meshheading:15709091-Soft Tissue Neoplasms
,
pubmed-meshheading:15709091-Taxoids
,
pubmed-meshheading:15709091-Thrombocytopenia
,
pubmed-meshheading:15709091-Urologic Neoplasms
pubmed:year
2005
pubmed:articleTitle
Combination chemotherapy of docetaxel, ifosfamide and cisplatin (DIP) in patients with metastatic urothelial cancer: a preliminary report.
pubmed:affiliation
Department of Urology, Faculty of Medicine, Tokyo University, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. takahashi-uro@h.u-tokyo.ac.jp
pubmed:publicationType
Journal Article
,
Clinical Trial